1715 — AI Health Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$160.54m
- HK$183.67m
- CNY47.40m
Annual cashflow statement for AI Health Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -43.7 | -43.2 | -49.3 | -36 | -36 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3.21 | 4.17 | 19.4 | 11.9 | 8.79 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 22.9 | -43.9 | 39.2 | -15.2 | 14.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11 | -75.9 | 14.6 | -35.2 | -10.1 |
| Capital Expenditures | -2.22 | -0.771 | -0.62 | -0.16 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 8.89 | 15.8 | 0.424 | 0.059 | 0.423 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.67 | 15 | -0.196 | -0.101 | 0.423 |
| Financing Cash Flow Items | -4.05 | -7.71 | -6.88 | -5.68 | -3.14 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -10.7 | 39.3 | 8.13 | 3.63 | 34.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.8 | -21 | 22.6 | -31.7 | 24.8 |